<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100211003329N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-04-01</date_registration>
      <primary_sponsor>Kashan University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Uriculotherapy on Depression in Elderly</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Uriculotherapy on Depression in Elderly</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54943</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: If subjects are satisfied with participating in the study, the selected qualifying samples will be randomly assigned to each of the two groups (intervention and control) in the form of block randomization in the form of 4 and 6 blocks. Using the Sealed Envelope Ltd software. 2017 Available Through www.sealedenvelope.com 4 -4-block and 6 -6-block, overall 10 blocks were defined that the allocation to groups would be based on the order specified by the software, Blinding description: Participants and outcome assessors are unaware of the nature of the seals pasted on participants' ears.</study_design>
      <phase>N/A</phase>
      <hc_freetext>depression.</hc_freetext>
      <i_freetext>Intervention 1: uriculotherapy will be performed twice a day for four weeks, five days a week. In this group, Korean-made Vakaria brand DONG BANG will be glued by a researcher on the points of Shenman, Zero, Hart, Antiperspirant, and Master-Cerebral that are associated with depression. The elderly will be instructed to press these sideways twice a day, 60 times each time with the index finger and thumb, according to the intended schedule. During the 4 weeks of the intervention, the labels will be affixed alternately on both ears by the researcher on a weekly basis. The labels are placed on the ear for five days each week and the elderly are instructed to remove them by the end of the fifth day or by those around them to prevent possible allergic reactions. It is also noted that if the Sides are separated during the five-day period, the researcher should be notified by telephone; In that case, the researcher, with the consent of the elderly person, will re-attach the sheets at his home, in the health center or wherever it is convenient for the elderly person. Each participant will be taught how to press the sidewalls by researcher. In addition, during the intervention, a weekly diary will be provided to the elderly person, in which he / she will specify the number of times each time the pressure and use of the new drug. The contents of the diary are organized using visual symbols in a way that can be understood and completed with simple training by all partcipants, including literate and illiterate. During the intervention period, all participants will be visited at the agreed location each week and new seeds will be affixed to them, and a diary will be delivered to them and another sheet will be delivered to them for the following week. Intervention 2: Control group:During the 4 weeks of the intervention, the labels will be affixed alternately on both ears by the researcher on a weekly basis. The labels are placed on the ear for five days each week and the elderly are instructed to remove them by the end of the fifth day or by those around them to prevent possible allergic reactions. It is also noted that if the Sides are separated during the five-day period, the researcher should be notified by telephone; In that case, the researcher, with the consent of the elderly person, will re-attach the sheets at his home, in the health center or wherever it is convenient for the elderly person. In addition, during the intervention, a weekly diary will be provided to the elderly person, in which he / she will specify signs of allergy and use of the new drug. The contents of the diary are organized using visual symbols in a way that can be understood and completed with simple training by all participants, including literate and illiterate. During the intervention period, all participants will be visited at the agreed location each week and new seeds will be affixed to them, and a diary will be delivered to them and another sheet will be delivered to them for the following week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Not done yet</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Tagharrobi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kashan University of Medical Sciences, Pezeshk Blvd, Ghotb Ravandi Blvd, Kashan</address>
        <city>Kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8715981151</zip>
        <telephone>+98 31 5554 0021</telephone>
        <email>tagharrobi_z@yahoo.com</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Tagharrobi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kashan University of Medical Sciences, Pezeshk Blvd, Ghotb Ravandi Blvd, Kashan</address>
        <city>kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8715981151</zip>
        <telephone>+98 31 5554 0021</telephone>
        <email>tagharrobi_z@yahoo.com</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 60 years and older
Willingness to participate in the study
Get a score higher than 25.5 from the COST tool
Iranian citizenship
Get a score higher than 5 from the GDS-15 tool
Ability to communicate in Persian
Organ health in the earlobe area</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Allergy to glue (allergies, redness) or any intolerance
Having a serious acute illness, hospitalization, lack of access
Simultaneous use of other non-pharmacological methods
using of acupuncture or acupuncture for the past three months
addiction to drugs and alcohol based on the contents of the electronic health record
exposure to severe stress (such as death of loved ones) from 3 months before the start of the study
using of drugs that affect mood from three weeks before the start of the study
Existence of other known psychiatric disorders and mental retardation based on the contents of the electronic health record</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F32.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other depressive episodes</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>uriculotherapy will be performed twice a day for four weeks, five days a week. In this group, Korean-made Vakaria brand DONG BANG will be glued by a researcher on the points of Shenman, Zero, Hart, Antiperspirant, and Master-Cerebral that are associated with depression. The elderly will be instructed to press these sideways twice a day, 60 times each time with the index finger and thumb, according to the intended schedule. During the 4 weeks of the intervention, the labels will be affixed alternately on both ears by the researcher on a weekly basis. The labels are placed on the ear for five days each week and the elderly are instructed to remove them by the end of the fifth day or by those around them to prevent possible allergic reactions. It is also noted that if the Sides are separated during the five-day period, the researcher should be notified by telephone; In that case, the researcher, with the consent of the elderly person, will re-attach the sheets at his home, in the health center or wherever it is convenient for the elderly person. Each participant will be taught how to press the sidewalls by researcher. In addition, during the intervention, a weekly diary will be provided to the elderly person, in which he / she will specify the number of times each time the pressure and use of the new drug. The contents of the diary are organized using visual symbols in a way that can be understood and completed with simple training by all partcipants, including literate and illiterate. During the intervention period, all participants will be visited at the agreed location each week and new seeds will be affixed to them, and a diary will be delivered to them and another sheet will be delivered to them for the following week.</i_keyword>
      <i_keyword>Control group:During the 4 weeks of the intervention, the labels will be affixed alternately on both ears by the researcher on a weekly basis. The labels are placed on the ear for five days each week and the elderly are instructed to remove them by the end of the fifth day or by those around them to prevent possible allergic reactions. It is also noted that if the Sides are separated during the five-day period, the researcher should be notified by telephone; In that case, the researcher, with the consent of the elderly person, will re-attach the sheets at his home, in the health center or wherever it is convenient for the elderly person. In addition, during the intervention, a weekly diary will be provided to the elderly person, in which he / she will specify signs of allergy and use of the new drug. The contents of the diary are organized using visual symbols in a way that can be understood and completed with simple training by all participants, including literate and illiterate. During the intervention period, all participants will be visited at the agreed location each week and new seeds will be affixed to them, and a diary will be delivered to them and another sheet will be delivered to them for the following week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Score of depression. Timepoint: Before the intervention - 4 weeks after the start of the intervention and 4 weeks after the end of the intervention. Method of measurement: Form 15 Questions for the Elderly Depression Scale (GDS-15).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kashan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-01</approval_date>
        <contact_name>Kashan University of Medical Sciences Ethics Committee</contact_name>
        <contact_address>Kashan University of Medical Sciences, Pezeshk Blvd, Ghotb Ravandi Blvd, Kashan kashan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
